Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Peter Mayne, QA Manager of OSI Pharmaceuticals will Present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA

Released on: June 18, 2008, 11:16 am

Press Release Author: GTC Bio

Industry: Biotech

Press Release Summary: Peter Mayne, QA Manager of OSI Pharmaceuticals will be
speaking at GTCbio's Global Clinical Trial Operations conference on September 25-26,
2008 in San Diego, CA. Dr. Mayne will present on being an EU Qualified Person (QP)
as a small offshoot of a virtual company.

Press Release Body: Since the introduction of the EU Clinical Trials Directive in
2004 it has been a requirement within Europe for investigational medicinal products
to be "certified" by a Qualified Person (QP) before they are used in a clinical
study. This talk will cover the role and responsibilities of the QP from the
perspective of a virtual US-based company with a single QA representative in the
U.K., concentrating on how the QP puts themselves in a position to certify that all
manufacturing operations are performed to standards equivalent to EU GMPs and in
accordance with European regulatory submissions. The presentation will cover common
US misunderestimations of the role of the QP and other potential pitfalls for
companies in similar positions.

The Global Clinical Trial Operations conference brings together leaders, directors,
vice presidents, heads, managers, supervisors, and CROs from all over the world to
collaborate and discuss the latest developments in clinical trial operations and
logistics and covers clinical trials in emerging markets, first-in-man clinical
trials, pediatric clinical trials, material storage, distribution, site selection,
patient recruitment and retention, technology in clinical trials and case studies of
running global clinical trials.

For more information including a detailed agenda, exhibitor opportunities and
registration information visit http://gtcbio.com/conferenceDetails.aspx?id=127.

ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.


Web Site: http://gtcbio.com/conferenceDetails.aspx?id=127

Contact Details: 434 W. Foothill Blvd.
Monrovia, CA 91016
Tel: (626) 256-6405
fax: (626) 256-6460
email: nina.tran@gtcbio.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •